Members |
targetComponentId |
démence épileptique |
Epilepsy co-occurrent and due to dementia |
Epileptic seizures - akinetic |
An epileptic seizure where cessation of movement and unresponsiveness are the predominant aspects of the entire seizure, regardless of whether focal, generalized or unknown onset. |
Epileptic seizures - myoclonic |
An epileptic seizure consisting of sudden, brief (less than 100 milliseconds) involuntary single or multiple contraction(s) of muscle(s) or muscle groups of variable topography (axial, proximal limb, distal), regardless of whether focal, generalised, or unknown onset, and whether aware or impaired awareness. Myoclonus is less regularly repetitive and less sustained than is clonus. |
Epinephrine |
Epinephrine (substance) |
Epinephrine [cardiovascular use] |
Product containing epinephrine (medicinal product) |
Epinephrine acid tartrate |
Epinephrine bitartrate (substance) |
Epiphora due to excess lacrimation |
Epiphora due to excess lacrimation |
Epiphrenic diverticulum |
Acquired supradiaphragmatic diverticulum of esophagus |
Epiphysial fracture, Salter-Harris Type I |
Salter-Harris type I |
Epiphysial fracture, Salter-Harris Type II |
Salter-Harris type II |
Epiphysial fracture, Salter-Harris Type III |
Salter-Harris type III (morphologic abnormality) |
Epiphysial fracture, Salter-Harris Type IV |
Salter-Harris type IV |
Epiphysial fracture, Salter-Harris Type V |
Salter-Harris type V |
Epiploic appendagitis due to ischemia |
Epiploic appendagitis |
Epiretinal membrane |
Epiretinal membrane |
surdose d'épirubicine d'intention indéterminée |
Epirubicin overdose |
intoxication par l'épirubicine d'intention indéterminée |
Epirubicin poisoning |
Episiorrhaphy |
Repair of episiotomy (procedure) |
Episiotomy |
Episiotomy |
Episodicities |
Episodicities |
Episodicities |
Episodicities |
Epispadias repair (including male) |
Epispadias repair |
Épistaxis |
Bleeding from nose |
Epistaxis control |
Control of hemorrhage of nose |
contrôle d'une épistaxis |
Control of hemorrhage of nose |
Epistaxis control - cautery |
Control of epistaxis by cautery (procedure) |
Epistaxis control - suture |
Control of epistaxis by suture |
Epistaxis control by cryosurgery |
Epistaxis control by cryosurgery |
Epithelial cell count |
Epithelial cell count (procedure) |
Epithelial cell count |
Epithelial cell count (procedure) |
Epithelial ependymoma |
Malignant ependymoma |
Epithelial membrane antigen |
Cancer antigen 15-3 |
Epithelial metaplasia |
Epithelial metaplasia |
Epithelial tumor |
Epithelial neoplasm |
Epithelial-myoepithelial carcinoma |
Epithelial-myoepithelial carcinoma |
Epithelialization -duplicate- |
Epithelialization |
Epithelioid cell naevus |
Epithelioid cell nevus |
Epithelioid cell sarcoma of skin |
Epithelioid cell sarcoma of skin |
Epithelioma basal cell |
Basal cell carcinoma of skin |
Epomophorus |
Genus Epomophorus (organism) |
Eponychium |
Structure of proximal nail fold |
Epoophoron cyst |
Embryonic cyst of epoophoron |
Epoprostenol sodium |
Epoprostenol sodium |
Eprosartan mesylate 400mg tablet |
Eprosartan (as eprosartan mesilate) 400 mg oral tablet |
Eprosartan mesylate 600mg tablet |
Eprosartan (as eprosartan mesilate) 600 mg oral tablet |
Epstein Barr virus viral capsid antigen IgM level |
Epstein Barr virus viral capsid antigen IgM level |
Epstein Barr virus viral capsid antigen IgM level |
Epstein Barr virus viral capsid antigen IgM level |
Epstein-Barr virus IgM antibody level |
Epstein-Barr virus IgM antibody measurement |
Epstein-Barr virus IgM antibody level |
Epstein-Barr virus IgM antibody measurement |
Epstein-Barr virus antibody titre |
Epstein-Barr virus antibody titer measurement |
Epstein-Barr virus antibody titre |
Epstein-Barr virus antibody titer measurement |
Epstein-Barr virus capsid IgG level |
Epstein-Barr virus capsid IgG measurement |
Epstein-Barr virus capsid IgG level |
Epstein-Barr virus capsid IgG measurement |
Epstein-Barr virus disease |
Epstein-Barr virus disease |
Epstein-Barr virus infection |
Epstein-Barr virus disease |
Epstein-Barr virus nuclear IgG level |
Epstein-Barr virus nuclear IgG measurement |
Epstein-Barr virus nuclear IgG level |
Epstein-Barr virus nuclear IgG measurement |
Eptacog alfa |
Eptacog alfa (substance) |
Equine rhinovirus 1 |
Equine rhinitis A virus (organism) |
Equine rhinovirus 2 |
Equine rhinitis B virus (organism) |
Equinus drop-foot-like gait |
Foot-drop gait |
Equinus gait |
Foot-drop gait |
Equus |
Genus Equus (organism) |
Equus burchellii |
Equus burchelli |
Equus caballus caballus |
Equus caballus (organism) |
Erb's muscular dystrophy |
Muscular dystrophy with predominantly proximal limb girdle distribution |
dystrophie musculaire des ceintures d'Erb |
Muscular dystrophy with predominantly proximal limb girdle distribution |
Erect abdom. X-ray requested |
Erect plain X-ray of abdomen requested (situation) |
Erect abdominal X-ray |
Erect plain X-ray of abdomen (procedure) |
Erect abdominal X-ray abnormal |
Erect plain X-ray of abdomen abnormal (finding) |
Erectile dysfunction constrictor ring |
Constrictor rings for erectile dysfunction (physical object) |
Ergocalciferol 50000unt |
Product containing precisely ergocalciferol 1.25 milligram/1 each conventional release oral capsule (clinical drug) |
Ergoloid mesylate |
Dihydroergotoxine mesilate |
Ergot alkaloid overdose of undetermined intent |
Ergot alkaloid overdose |
Ergot alkaloid poisoning of undetermined intent |
Poisoning by ergot alkaloid |
Ergot compound adverse reaction |
Ergot alkaloid adverse reaction (disorder) |
Ergot preparation |
Ergot alkaloid-containing product |
Ergotamine + caffeine |
Product containing caffeine and ergotamine (medicinal product) |
Ergotamine product |
Product containing ergotamine (medicinal product) |
Erosive adenomatosis of nipple |
Adenoma of nipple |
Erotism, function (observable entity) |
Eroticism |
Erotomania |
Erotomania (disorder) |
Error entry deleted |
Error entry deleted (finding) |
Eruptive lentiginosis |
Eruptive lentiginosis |
Erysipelas |
Erysipelas |
Erythema ab igne |
Erythema ab igne |
Erythema ab igne |
Erythema ab igne |
Erythema annulare rheumaticum |
Erythema marginatum in acute rheumatic fever |
Erythema chronicum migrans |
Erythema chronica migrans |
Erythema elevatum diutinum |
Erythema elevatum diutinum |
Erythema gyratum repens |
Erythema gyratum repens |
lupus érythémateux semblable à l'érythème multiforme |
Lupus erythematosus and erythema multiforme-like syndrome |
érythème noueux lépreux |
Type 2 lepra reactions (erythema nodosum leprosum), are associated with circulation and tissue deposition of immune complexes. They are an antibody response or immune complex response to M. leprae antigenic determinants which occur only in multibacillary leprosy. (WHO) |
Erythema toxicum neonatorum |
Neonatal erythroderma |
Erythema venenatum |
Neonatal erythroderma |
Erythema venenatum |
Neonatal erythroderma |
Erythematosquamous dermatosis |
Erythematosquamous dermatosis |
Erythematous mucosa |
Mucous membrane erythema |
plaques érythémateuses de la pinta |
Erythematous pinta plaque |
Erythrasma |
Erythrasma |
Erythrocyte hemoglobin distribution width |
Hemoglobin distribution, width determination |